Quantitative Systematic Strategies LLC Adverum Biotechnologies, Inc. Transaction History

Quantitative Systematic Strategies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$9.84 - $14.26 $396,945 - $575,248	-40,340 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$10.3 - $21.64 $110,179 - $231,483	10,697 Added 36.09%	40,340 $416,000
Q2 2020 Aug 04, 2020	BUY	$8.53 - $25.64 $13,127 - $39,459	1,539 Added 5.48%	29,643 $619,000
Q1 2020 May 06, 2020	SELL	$7.98 - $16.32 $75,722 - $154,860	-9,489 Reduced 25.24%	28,104 $275,000
Q4 2019 Feb 11, 2020	BUY	$5.12 - $12.22 $63,779 - $152,224	12,457 Added 49.56%	37,593 $433,000
Q3 2019 Nov 07, 2019	BUY	$5.24 - $15.89 $131,712 - $399,411	25,136 New	25,136 $137,000
Q4 2018 Feb 12, 2019	SELL	$2.87 - $5.92 $32,359 - $66,748	-11,275 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$4.5 - $7.6 $50,737 - $85,690	11,275 New	11,275 $68,000

2.53M

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $748M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.